Health Economics›Breast cancer›Adjuvant therapy, sequential regimens

Adjuvant therapy, sequential regimens

Breast cancer · 2 regimens

Cost estimates only — modelled on a typical patient (BSA 1.7 m², 70 kg, CrCl 90 mL/min) using the cheapest available formulary presentation. Excludes vial wastage, facility fees, supportive care, and infusion consumables. Not for billing, formulary decisions, or clinical use.

FiltersBiomarker

Y-axis

Cost vs Efficacy

No data points — cost or PFS missing for current selection.

Regimen	Biomarker	Cost/cycle ↓	Cycle	PFS ↕	OS ↕	Est. cycles	Course cost ↕	Evidence
T-EC Variant #01	TNBC	R 2 938	28d	—	—	~12	~R 16 649 indirect	—
T-AC Variant #01	TNBC	R 1 382	21d	—	—	~12	~R 10 425 indirect	—

2 of 2 regimens shown